中华眼科杂志
中華眼科雜誌
중화안과잡지
Chinese Journal of Ophthalmology
2014年
10期
725-728
,共4页
视网膜母细胞瘤%肿瘤浸润%危险因素
視網膜母細胞瘤%腫瘤浸潤%危險因素
시망막모세포류%종류침윤%위험인소
Retinoblastoma%Neoplasm invasiveness%Risk factors
组织病理学高危因素是视网膜母细胞瘤(RB)眼球摘除术后组织病理学检查的核心内容.RB组织病理学高危因素预示患者术后具有较高的肿瘤扩散和转移风险,需要在术后进行全身辅助性化学治疗.因此,RB组织病理学高危因素可为临床医师确定治疗方案提供重要依据,同时也是相关临床研究确定标准的重要基础.本文重点讨论评估RB组织病理学高危因素的方法、临床特征能否预测RB组织病理学高危因素、RB组织病理学高危因素评估对经眼动脉化学治疗的提示作用等问题,提出了评估RB组织病理学高危因素的重要性,以期引起临床关注.
組織病理學高危因素是視網膜母細胞瘤(RB)眼毬摘除術後組織病理學檢查的覈心內容.RB組織病理學高危因素預示患者術後具有較高的腫瘤擴散和轉移風險,需要在術後進行全身輔助性化學治療.因此,RB組織病理學高危因素可為臨床醫師確定治療方案提供重要依據,同時也是相關臨床研究確定標準的重要基礎.本文重點討論評估RB組織病理學高危因素的方法、臨床特徵能否預測RB組織病理學高危因素、RB組織病理學高危因素評估對經眼動脈化學治療的提示作用等問題,提齣瞭評估RB組織病理學高危因素的重要性,以期引起臨床關註.
조직병이학고위인소시시망막모세포류(RB)안구적제술후조직병이학검사적핵심내용.RB조직병이학고위인소예시환자술후구유교고적종류확산화전이풍험,수요재술후진행전신보조성화학치료.인차,RB조직병이학고위인소가위림상의사학정치료방안제공중요의거,동시야시상관림상연구학정표준적중요기출.본문중점토론평고RB조직병이학고위인소적방법、림상특정능부예측RB조직병이학고위인소、RB조직병이학고위인소평고대경안동맥화학치료적제시작용등문제,제출료평고RB조직병이학고위인소적중요성,이기인기림상관주.
Histopathologic high risk factors are core content in the histopathologic examination of enucleated retinoblastoma.Histopathologic high risk factors indicate that the patient has high risk of tumor spreading and metastasizing and should be given systemic adjuvant chemotherapy.Therefore,histopathologic high risk factors can provide important basis for clinicians to determine treatment plan and serve as the important foundation for clinical trials and studies to validate the proposed criteria.The focus of our discussion includes three aspects as follows.How to evaluate histopathologic high risk factors? Can clinical characteristics be used to predict histopathologic high risk factors? Do histopathologic high risk factors have any hint for intra-arterial chemotherapy? The importance of evaluating histopathologic high risk factors in retinoblastoma is emphasized in this article.